SEC Form 4 · accession 0001209191-17-059423
PULSE BIOSCIENCES, INC. · PLSE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W Duggan
Director · 10% Owner
Period of report
Nov 2, 2017
Accepted (ET)
Nov 6, 2017 · 4:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001625101
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $23.08 | Nov 2, 2017 | A | 65,000 | A | Nov 2, 2018 | Nov 2, 2027 | Common Stock | 65,000 | 65,000 | D |
Explanation of responses
- F1One-third (1/3) of the shares subject to the option will vest on November 2, 2018, and the remaining shares will vest in equal monthly installments thereafter over the following two year period, subject to the Reporting Person's continued service through each vesting date.